Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age

Similar Items

• A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
  od: van Gelder, C, i dr.
  Izdano: (2013)
• Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease
  od: van Gelder, Carin M., i dr.
  Izdano: (2014)
• Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
  od: Ebbink, BJ, i dr.
  Izdano: (2013)
• Impact of enzyme replacement therapy on survival in adults with Pompe disease
  od: Güngör, Deniz, i dr.
  Izdano: (2013)
• Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
  od: Kanters, Tim A, i dr.
  Izdano: (2014)